Complex Esophageal Reconstruction Procedures Have Acceptable Outcomes Compared With Routine Esophagectomy  Jessica M. Moore, BS, Craig M. Hooker, PhD,

Slides:



Advertisements
Similar presentations
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Advertisements

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer  Yoichi.
Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Outcomes of Reintervention on the Autograft After Ross Procedure
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
Emergent Esophagectomy for Esophageal Perforations: A Safe Option
Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer  Lars P. Riber, MD, PhD, Thomas D. Christensen,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy 
Castigliano M. Bhamidipati, DO, MS, George J
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Operative Results and Outcomes in Children With Shone's Anomaly
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Andrea S. Wolf, MD, MPH, Scott J
Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M
Age-Related Outcomes of the Ross Procedure Over 20 Years
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Elizabeth H. Stephens, MD, PhD, Arlene M. Correa, PhD, Min P
Positron Emission Tomography-Computed Tomography for Postoperative Surveillance in Non-Small Cell Lung Cancer  Se Hoon Choi, MD, Young Tae Kim, MD, PhD,
Long-Term Outcomes of the Mosaic Bioprosthesis
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Who Do You Say You Are? The Annals of Thoracic Surgery
Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival  Pamela Samson, MD, MPHS, Traves.
Abel Gómez-Caro, MD, Pedro Arguis, MD  The Annals of Thoracic Surgery 
Michael Lanuti, MD, Pierre E
Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D
Outcomes After Transhiatal and Transthoracic Esophagectomy for Cancer
Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D
Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma  Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B.
Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response.
Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy  Pamela Samson, MD, MPHS,
Lucas W. Thornblade, MD, Aaron M. Cheng, MD, Douglas E
Editorial Board, January 2010
Understanding Mortality as a Quality Indicator After Esophagectomy
William M. Whited, MD, Paul Henley, BS, Erin M
PillCam in Gastric Conduit After Ivor Lewis Esophagectomy
A. Thomas Pezzella, MD, Sari D
Scott P. Kaiser, BS, Spencer J
Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent?  Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,
Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P
Specialty Training and Mortality After Esophageal Cancer Resection
Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer  Pamela Samson, MD, MPHS, Varun.
Results of Thoracic Endovascular Aortic Repair 6 Years After United States Food and Drug Administration Approval  Asad A. Shah, MD, Michael E. Barfield,
Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer?  Williams Tessier, MD, Caroline Gronnier, MD,
Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T.
Nabin K. Shrestha, MD, MPH, Jennifer Jue, MD, Syed T
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD, Aalok Patel,
Neoadjuvant Chemoradiation Therapy Is Beneficial for Clinical Stage T2 N0 Esophageal Cancer Patients Due to Inaccurate Preoperative Staging  Jennifer.
Current Outcomes of Surgical Management of Aortopulmonary Window and Associated Cardiac Lesions  Bahaaldin Alsoufi, MD, Brian Schlosser, BS, RDCS, Courtney.
“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation
Left-Sided Reoperations After Arterial Switch Operation: A European Multicenter Study  Vladimiro L. Vida, MD, PhD, Lorenza Zanotto, MD, Lucia Zanotto,
Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J
Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis  Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.
Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures  Simon Maltais, MD, PhD,
Phillip S. Naimo, BS, Matthew S
The Impact of New Technology on Cardiothoracic Surgical Practice
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy  Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy  Tomas Gudbjartsson,
Surgical Outcomes of Acute Type A Aortic Dissection in Elderly Patients  Kazunori Komatsu, MD, Tamaki Takano, MD, PhD, Takamitsu Terasaki, MD, Yuko Wada,
Presentation transcript:

Complex Esophageal Reconstruction Procedures Have Acceptable Outcomes Compared With Routine Esophagectomy  Jessica M. Moore, BS, Craig M. Hooker, PhD, MPH, Daniela Molena, MD, Benedetto Mungo, MD, Malcolm V. Brock, MD, Richard J. Battafarano, MD, PhD, Stephen C. Yang, MD  The Annals of Thoracic Surgery  Volume 102, Issue 1, Pages 215-222 (July 2016) DOI: 10.1016/j.athoracsur.2016.02.039 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier estimates of overall survival after esophagectomy according to CER for benign indication (n = 80). (CER = complex esophageal reconstruction; NCER = non-CER.) The Annals of Thoracic Surgery 2016 102, 215-222DOI: (10.1016/j.athoracsur.2016.02.039) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier estimates of overall survival after esophagectomy according to CER for cancer indication (n = 70). (CER = complex esophageal reconstruction; NCER = non-CER.) The Annals of Thoracic Surgery 2016 102, 215-222DOI: (10.1016/j.athoracsur.2016.02.039) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions